Author: Menéndez, Cintia A.; Byléhn, Fabian; Perez-Lemus, Gustavo R.; Alvarado, Walter; de Pablo, Juan J.
Title: Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease Cord-id: emzr3dzb Document date: 2020_9_11
ID: emzr3dzb
Snippet: There is an urgent need to repurpose drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent computational-experimental screenings have identified several existing drugs that could serve as effective inhibitors of the virus’ main protease, M(pro), which is involved in gene expression and replication. Among these, ebselen (2-phenyl-1,2-benzoselenazol-3-one) appears to be particularly promising. Here, we examine, at a molecular level, the potential of ebselen to decrea
Document: There is an urgent need to repurpose drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent computational-experimental screenings have identified several existing drugs that could serve as effective inhibitors of the virus’ main protease, M(pro), which is involved in gene expression and replication. Among these, ebselen (2-phenyl-1,2-benzoselenazol-3-one) appears to be particularly promising. Here, we examine, at a molecular level, the potential of ebselen to decrease M(pro) activity. We find that it exhibits a distinct affinity for the catalytic region. Our results reveal a higher-affinity, previously unknown binding site localized between the II and III domains of the protein. A detailed strain analysis indicates that, on such a site, ebselen exerts a pronounced allosteric effect that regulates catalytic site access through surface-loop interactions, thereby inducing a reconfiguration of water hotspots. Together, these findings highlight the promise of ebselen as a repurposed drug against SARS-CoV-2.
Search related documents:
Co phrase search for related documents- active site and low cytotoxicity: 1, 2
- long range and low strain: 1
Co phrase search for related documents, hyperlinks ordered by date